DISCLAIMER
DISCLAIMER: The author is not a registered stockbroker nor a registered advisor and does not give investment advice. His comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to buy or sell a stock, option, future, bond, commodity, index or any other financial instrument at any time. While he believes his statements to be true, they always depend on the reliability of his own credible sources. The author recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction, before making any investment decisions, and that you confirm the facts on your own before making important investment commitments.
GSK settles more lawsuits over Avandia
Thousands of lawsuits alleging that drug maker GlaxoSmithKline’s diabetes drug Avandia caused heart attacks were settled, the company confirmed today.
The cases were originally scheduled to go to court in Philadelphia this month. GlaxoSmithKline declined to provide details of the settlement.
Posts
No comments:
Post a Comment